Burch SP, Davis KH, Fehnel SE, Nelsen AC, Hill CD, Shashidhar KH. Outcomes, impact and behavior associated with acute treatment of migraine. Poster presented at the 16th Migraine Trust International Symposium; November 2006. [abstract] Cephalalgia. 2006 Nov; 26(11):1358-403.
Burch SP, Davis KH, Fehnel SE, Nelsen AC, Hill CD, Kori SH. The migraine assessment of current therapy (Migraine-ACT): a useful tool for detecting differences in outcomes between migraine therapies. Poster presented at the Migraine Trust International Symposium; September 2006.
Reisetter BC, Dunson DH, Kolassa EM, Schwab P. CPMM Policy Report. Effect of Medicare part D reimbursement on community pharmacy profitability. 2006. Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi.
Thase MF, Fava M, Hollander S, Simmons JH, Ivgy-May N, Boyle K, Gibertini M. Analysis of the effects of gepirone-ER on the Bech-6 and individual HAM-D 17-item scores. Poster presented at the 2003 42nd ACNP Annual Meeting; December 2003. San Juan, Puerto Rico.
Sapienza S, Sacco P, Floyd K, DiCesare J, Doan Q. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting. Clin Ther. 2003 Jun;25(6):1872-87.
Price MA, Fiore T, Tanner A, Bernier K, Puma M, Magliocca L. Evaluation of the state improvement grant (SIG) program—updated cross project analysis report. 2003.